BODY Stock UPDATES Body Central (BODY) 0.8000 10/22/2014 04:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Body Central (BODY) 0.8000 $BODY

Body Central Corp. Clarifies That 1-for-10 Reverse Stock Split Anticipated to be Effective for Trading Purposes on Tuesday, September 9
GlobeNewswire - Fri Sep 05, 4:17PM CDT
Body Central Corp. (OTC Pink:BODY) (the "Company" , a multi-channel, specialty retailer offering on trend, quality apparel and accessories at value prices, issued a press release on September 4, 2014 announcing that it is effecting a 1-for-10 reverse stock split of its common stock (the "Reverse Stock Split" , pursuant to which each 10 shares of issued and outstanding common stock and equivalents are being converted into 1 share of common stock. The Company wishes to issue a clarification as to the timing pursuant to which the Reverse Stock Split is being implemented.

Body Central Corp. Announces 1-for-10 Reverse Stock Split; Other Changes to Governance Documents Approved at Special Meeting
GlobeNewswire - Thu Sep 04, 4:14PM CDT
Body Central Corp. (OTC Pink:BODY) (the "Company" , a multi-channel, specialty retailer offering on trend, quality apparel and accessories at value prices, announced that it is effecting a 1-for-10 reverse stock split of its common stock which will be effective as of 5:00 p.m. EDT today, September 4, 2014 (the "Split Effective Time" . At the Split Effective Time, each 10 shares of issued and outstanding common stock and equivalents will be converted into 1 share of common stock. In addition, at and following the Split Effective Time, the common stock will trade under a new CUSIP number 09689U201 although the Company's trading symbol, BODY, will remain unchanged.

Body Central Corp. Responds to Investor Questions
GlobeNewswire - Fri Aug 29, 4:46PM CDT
Body Central Corp. (OTC Pink:BODY) (the "Company" recently filed a press release dated August 14, 2014, communicating the results of operations for the thirteen weeks ended June 28, 2014. Within the communication, investors were offered the opportunity to submit relevant questions to the Company. The questions and answers below reflect responses to a sampling of the questions received.

Body Central Corp. Announces Second Quarter 2014 Financial Results
GlobeNewswire - Thu Aug 14, 4:26PM CDT
Body Central Corp. (OTC - Pink: BODY) (the "Company" today announced financial results for the second quarter of 2014.

Body Central Corp. Appoints Three New Directors
GlobeNewswire - Thu Jul 31, 12:02PM CDT
Body Central Corp. (OTC PINK:BODY) (the "Company" is pleased to announce the expansion of its Board of Directors and the appointment of three new directors effective July 31, 2014. The following individuals have been elected to the Board of Directors and help to round out the Board's expertise in the retail operations, supply chain, e-commerce, and public accounting sectors.

Body Central Common Stock to Move to Over the Counter Market
GlobeNewswire - Wed Jul 09, 9:17AM CDT
Body Central Corp. (Nasdaq:BODY), today announced that trading of the Company's common stock on the NASDAQ Stock Market ("NASDAQ" will be suspended prior to the opening of trading today. The Company anticipates that its common stock will be immediately eligible for quotation on the OTC Pink Marketplace at the opening of trading today under the same symbol ("BODY" . The OTC Pink Marketplace is a market tier operated by OTC Markets Group Inc. for over-the-counter traded companies.

Body Central Corp. Announces $18 Million Private Placement of Subordinated Secured Convertible Notes
GlobeNewswire - Mon Jun 30, 7:57AM CDT
Body Central Corp. (Nasdaq:BODY), today announced that it has completed the previously announced review of financing, transactional and strategic alternatives with the closing of a private placement of $18.0 million in principal amount of its 7.5% subordinated secured convertible notes (the "notes" . Interest on the notes will accrue at 7.5% per annum and each quarterly interest payment will be paid in kind by increasing the principal amount due under the notes unless the Company exercises its option to pay cash interest at a rate of 6.75% per annum. The notes are convertible into shares of the Company's common stock at any time at the option of the holder thereof at a conversion price of $0.35, subject to certain adjustments. All amounts will be due and payable in cash on the third anniversary of the issue date, unless earlier converted. In addition, the Company issued new series of its preferred stock, with nominal value, to the holders of the notes granting the power to vote the shares of common stock underlying the notes as if the notes were converted in full. The terms of the preferred stock will grant three of the investors the ability to each elect one director to the Company's board of directors. The Company plans to seek stockholder approval within 90 days for a reverse stock split.

Stock to Watch: Body Central Down 5.9% (BODY)
Comtex SmarTrend(R) - Fri Jun 27, 12:44PM CDT
Body Central (NASDAQ:BODY) is one of today's worst performing penny stocks, down 5.9% to $0.95 on 1.2x average daily volume. Body Central has traded 529,000 shares thus far today, vs. average volume of 427,000 shares per day. The stock has underperformed the Dow (-5.9% to the Dow's -0.4%) and underperformed the S&P 500 (-5.9% to the S&P's -0.2%) during today's trading.

4 Stocks Under $10 Making Big Moves
at The Street - Fri Jun 13, 5:00AM CDT
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
IO: 2.88 (+0.09), BPTH: 2.41 (+0.05), ICLD: 3.70 (unch)

Hot Stock: Body Central, Shares Gain 20.9% (BODY)
Comtex SmarTrend(R) - Fri Mar 28, 11:40AM CDT
Body Central (NASDAQ:BODY) is one of today's best performing low-priced stocks, up 20.9% to $1.10 on 6.8x average daily volume. Body Central has traded 2.9 million shares thus far today, vs. average volume of 433,000 shares per day. The stock has outperformed the Dow (20.9% to the Dow's 0.7%) and outperformed the S&P 500 (20.9% to the S&P's 0.7%) during today's trading.

Body Central (BODY) Stock Hits 52-Week Low as Sell-Off Continues
at The Street - Thu Mar 27, 2:07PM CDT
Body Central (BODY) hit a 52-week low earlier Thursday, a day after negative results in its year-ending quarter sparked a sell-off.

International Game Technology Cuts Previously Issued Guidance
ACCESSWIRE - Thu Mar 27, 4:05AM CDT
International Game Technology (NYSE: IGT) - For an in-depth report on International Game Technology follow: www.BullTrends.com/stockquote/IGT
ISR: 1.42 (+0.02), IGT: 16.40 (+0.27)

Nasdaq stocks posting largest volume increases
AP - Wed Mar 26, 5:04PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
NVEE: 9.30 (+0.20), INSM: 13.63 (+0.11), PDII: 1.71 (-0.08), EXEL: 1.60 (-0.05)

Why Body Central (BODY) Stock Is Plummeting
at The Street - Wed Mar 26, 9:10AM CDT
Body Central (BODY) shares are plummeting before the bell Wednesday after the company said it was growing more likely it would not be able to continue as a going concern after reporting negative results in its year-ending quarter.

Body Central Corp. Announces Fourth Quarter 2013 Financial Results
GlobeNewswire - Tue Mar 25, 3:30PM CDT
Body Central Corp. (Nasdaq:BODY) today announced financial results for the fourth quarter of 2013.

Body Central Corp. Announces Reporting Date for Fourth Quarter and Fiscal 2013 Financial Results
GlobeNewswire - Mon Mar 24, 3:19PM CDT
Body Central Corp. (Nasdaq:BODY) today announced that it plans to report its fourth quarter and fiscal 2013 financial results on Tuesday, March 25, 2014, after the market close. The Company also plans to hold a conference call to discuss its financial results the same day at 4:30 p.m. ET.

Investors look to Lighten Up on Shares of Body Central, Shares Down 6.5% (BODY)
Comtex SmarTrend(R) - Mon Mar 24, 12:46PM CDT
Body Central (NASDAQ:BODY) is one of today's worst performing low-priced stocks, down 6.5% to $1.87 on 1.1x average daily volume. Body Central has traded 387,000 shares thus far today, vs. average volume of 361,000 shares per day. The stock has underperformed the Dow (-6.5% to the Dow's -0.3%) and underperformed the S&P 500 (-6.5% to the S&P's -0.6%) during today's trading.

Why Body Central Corp (BODY) Is Tanking on Friday
at The Street - Fri Mar 14, 2:44PM CDT
Body Central Corp (BODY) is tanking on Friday after filing a notice with the Securities and Exchange Commission (SEC) explaining it would not be able to complete its 10-K as scheduled.

Stock to Watch: Body Central Down 22.5% (BODY)
Comtex SmarTrend(R) - Fri Mar 14, 10:10AM CDT
Body Central (NASDAQ:BODY) is one of today's worst performing low-priced stocks, down 22.5% to $2.20 on 3.7x average daily volume. Body Central has traded 862,000 shares thus far today, vs. average volume of 230,000 shares per day. The stock has underperformed the Dow (-22.5% to the Dow's -0.1%) and underperformed the S&P 500 (-22.5% to the S&P's -0.1%) during today's trading.

CPP Investment Board Reports Fiscal Third Quarter Performance Results
Marketwire Canada - Fri Feb 14, 8:00AM CST
The CPP Fund ended the third quarter of its 2014 fiscal year on December 31, 2013 with net assets of $201.5 billion, compared to $192.8 billion at the end of the previous quarter. The $8.7 billion increase in assets for the quarter comprised $11.1 billion in net investment income, after operating costs, less $2.4 billion of cash outflows. The CPP Fund routinely receives more CPP contributions than are required to pay benefits during the first part of the calendar year and then remits a portion of those funds for benefit payments in the latter part of the year. The portfolio delivered a gross investment return of 5.9% for the quarter.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 445

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 222

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 198

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 216

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 163

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 152

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 306

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 392

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 410

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 314

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights on Stocks: Applied Materials, Coupang, and Starbucks

Updated Category News Views 176

Market Highlights from CNBC's Final Trades In the latest episode of CNBC's “Halftime Report Final Trades,” Jim Lebenthal from Cerity Partners highlighted a compelling trade with Applied Materials, Inc. (NASDAQ: AMAT), suggesting it's one to watch closely in the current market environment. Applied Materials: Recent Developments Recently, applied materials found itself...

Continue Reading
Investors Urged to Take Action on Biohaven Ltd. Lawsuit

Updated Category News Views 101

Key Details for Biohaven Ltd. Investors Attention investors! If you've acquired securities of Biohaven Ltd. between certain dates, it's crucial to know about an ongoing class action lawsuit that may affect you. Now is the time to ensure your rights are protected. Why You Should Act Now The Rosen Law Firm has announced an important deadline for those who purchased Biohaven...

Continue Reading
ProPhase Labs Inc. Growth Update: Strategies & Innovations

Updated Category News Views 141

ProPhase Labs Inc. Update Overview Diamond Equity Research has recently published a significant update on ProPhase Labs Inc. (NASDAQ: PRPH), shedding light on the company’s strategic initiatives and innovations. This analysis explores ProPhase's evolving business model, its position within the industry, financial performance, and potential market risks. Growth...

Continue Reading
Donaldson Company Reports Record Sales and Ambitious 2026 Goals

Updated Category News Views 216

Donaldson Company Reports Outstanding Results for Fourth Quarter Donaldson Company (NYSE: DCI) has recently provided an impressive overview of its fourth-quarter and full-year fiscal 2025 performance. The company reported remarkable sales figures and notable earnings that reflect its ability to navigate market challenges effectively. With guidance for fiscal 2026 now in...

Continue Reading
Brandywine Realty Trust's 2024 Financial Performance Revealed

Updated Category News Views 189

Brandywine Realty Trust Reports Impressive Results for 2024 In a recent announcement, Brandywine Realty Trust (NYSE: BDN) showcased its financial and operational results for 2024, indicating strong performance across several metrics. As the company evaluates these results, it prepares for an even more promising outlook in 2025. Remarkable Achievements in 2024 Operational...

Continue Reading